Rationale for intensive intravesical chemotherapy for superficial bladder cancer

M. S. Soloway

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

The high incidence of vesical tumors after initial management of a superficial tumor (stages 0 and A) presents a major therapeutic challenge to the urologist. This incidence of subsequent tumors ranges from 40 to 70 per cent and is consistent among several series. Most of these tumors will occur within 6 to 12 months. I herein review some factors accounting for this high incidence and suggest a therapeutic strategy that might delay or prevent these rapid recurrences.

Original languageEnglish
Pages (from-to)461-466
Number of pages6
JournalJournal of Urology
Volume123
Issue number4
StatePublished - Jan 1 1980
Externally publishedYes

Fingerprint

Urinary Bladder Neoplasms
Drug Therapy
Incidence
Neoplasms
Recurrence
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Rationale for intensive intravesical chemotherapy for superficial bladder cancer. / Soloway, M. S.

In: Journal of Urology, Vol. 123, No. 4, 01.01.1980, p. 461-466.

Research output: Contribution to journalArticle

@article{72d0d28c26e84540905b37abdc58bcba,
title = "Rationale for intensive intravesical chemotherapy for superficial bladder cancer",
abstract = "The high incidence of vesical tumors after initial management of a superficial tumor (stages 0 and A) presents a major therapeutic challenge to the urologist. This incidence of subsequent tumors ranges from 40 to 70 per cent and is consistent among several series. Most of these tumors will occur within 6 to 12 months. I herein review some factors accounting for this high incidence and suggest a therapeutic strategy that might delay or prevent these rapid recurrences.",
author = "Soloway, {M. S.}",
year = "1980",
month = "1",
day = "1",
language = "English",
volume = "123",
pages = "461--466",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Rationale for intensive intravesical chemotherapy for superficial bladder cancer

AU - Soloway, M. S.

PY - 1980/1/1

Y1 - 1980/1/1

N2 - The high incidence of vesical tumors after initial management of a superficial tumor (stages 0 and A) presents a major therapeutic challenge to the urologist. This incidence of subsequent tumors ranges from 40 to 70 per cent and is consistent among several series. Most of these tumors will occur within 6 to 12 months. I herein review some factors accounting for this high incidence and suggest a therapeutic strategy that might delay or prevent these rapid recurrences.

AB - The high incidence of vesical tumors after initial management of a superficial tumor (stages 0 and A) presents a major therapeutic challenge to the urologist. This incidence of subsequent tumors ranges from 40 to 70 per cent and is consistent among several series. Most of these tumors will occur within 6 to 12 months. I herein review some factors accounting for this high incidence and suggest a therapeutic strategy that might delay or prevent these rapid recurrences.

UR - http://www.scopus.com/inward/record.url?scp=0018826157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018826157&partnerID=8YFLogxK

M3 - Article

VL - 123

SP - 461

EP - 466

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 4

ER -